Zero-premium drug plans disappear in 2027 as federal subsidy ends

A KFF analysis finds 2.4 million Part D enrollees face monthly premium increases above $50, a 63-fold rise from the prior year

Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.

Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.